[{"address1": "301 Binney Street", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 655 7500", "website": "https://generationbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 115, "companyOfficers": [{"maxAge": 1, "name": "Ms. Antoinette  Paone M.B.A., M.S.", "age": 46, "title": "Chief Operating Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 681155, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Phillip  Samayoa Ph.D.", "age": 38, "title": "Chief Scientific Officer", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 680956, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yalonda  Howze J.D.", "age": 53, "title": "Interim CEO & President", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 568809, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark D. Angelino Ph.D.", "age": 52, "title": "Co-Founder", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert  Kotin Ph.D.", "age": 69, "title": "Co-Founder", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin John Conway", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jasmin  Tower", "title": "Chief Human Resources Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caitlin  Cooper M.B.A.", "title": "Senior VP & Head of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.34, "open": 5.7, "dayLow": 5.34, "dayHigh": 5.705, "regularMarketPreviousClose": 5.34, "regularMarketOpen": 5.7, "regularMarketDayLow": 5.34, "regularMarketDayHigh": 5.705, "payoutRatio": 0.0, "beta": 2.006, "forwardPE": -3.9850748, "volume": 551924, "regularMarketVolume": 551924, "averageVolume": 83317, "averageVolume10days": 129069, "averageDailyVolume10Day": 129069, "bid": 5.31, "ask": 5.44, "bidSize": 100, "askSize": 100, "marketCap": 35983832, "fiftyTwoWeekLow": 3.004, "fiftyTwoWeekHigh": 7.516, "allTimeHigh": 557.2, "allTimeLow": 3.004, "priceToSalesTrailing12Months": 2.3565052, "fiftyDayAverage": 5.5184, "twoHundredDayAverage": 5.111025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -27545620, "profitMargins": 0.0, "floatShares": 4186661, "sharesOutstanding": 6738545, "sharesShort": 2068, "sharesShortPriorMonth": 47657, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.00029999999, "heldPercentInsiders": 0.14292, "heldPercentInstitutions": 0.66073996, "shortRatio": 0.03, "shortPercentOfFloat": 0.0004, "impliedSharesOutstanding": 6738545, "bookValue": 7.506, "priceToBook": 0.71143085, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -62627000, "trailingEps": -9.37, "forwardEps": -1.34, "lastSplitFactor": "1:10", "lastSplitDate": 1753142400, "enterpriseToRevenue": -1.804, "enterpriseToEbitda": 0.361, "52WeekChange": -0.23110151, "SandP52WeekChange": 0.11527538, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "GBIO", "underlyingSymbol": "GBIO", "shortName": "Generation Bio Co.", "longName": "Generation Bio Co.", "firstTradeDateEpochUtc": 1591968600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "de72dc9d-13d8-33a4-9b40-561570d3fd58", "messageBoardId": "finmb_548482897", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.34, "recommendationKey": "none", "totalCash": 89622000, "totalCashPerShare": 13.301, "ebitda": -76380000, "totalDebt": 26096000, "quickRatio": 4.278, "currentRatio": 4.442, "totalRevenue": 15270000, "debtToEquity": 51.614, "revenuePerShare": 2.277, "returnOnAssets": -0.27392, "returnOnEquity": -0.80807996, "grossProfits": -32398000, "freeCashflow": -40196752, "operatingCashflow": -113652000, "revenueGrowth": -0.789, "grossMargins": -2.12168, "ebitdaMargins": 0.0, "operatingMargins": -20.1995, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]